Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006695

Locations


United States, Nebraska
	UNMC Eppley Cancer Center at the University of Nebraska Medical Center
	Omaha, Nebraska, United States, 68198-6805

Sponsors and Collaborators

University of Nebraska

Investigators


Study Chair:	Julie M. Vose, MD	University of Nebraska